As summarized in Table 2, the observed effect sizes ranged from moderate (RF-positive vs. negative) to large (anti-CCP and double-positive vs. double-negative), underscoring the clinical relevance of ISM1 reductions in autoantibody-positive RA. Here, ISM1 is linked to rheumatoid arthritis.